Carmichael Roberts

TR T’90, G’95, General Partner, North Bridge Venture Partners

Carmichael Roberts

Carmichael Roberts is a General Partner at North Bridge Venture Partners where he finances and builds companies that make new products using chemistry, materials science and/or materials engineering. He primarily focuses on very early stage ventures, including helping founders launch companies from initial formation.

Prior to joining North Bridge, Carmichael co-founded several companies including Arsenal Medical, 480 Biomedical, Diagnostics For All and Surface Logix. He has served in an executive and/or Chairman capacity for each of his companies.

Before starting his career as an entrepreneur, Carmichael worked at GelTex Pharmaceuticals (acquired by Genzyme) and previously at Sentry Products, a life science venture wholly owned by Union Carbide Corporation (acquired by Dow Chemical).

Carmichael received his B.S. and Ph.D. in organic chemistry from Duke University and was a National Science Foundation Fellow at Harvard University’s Departments of Chemistry and Chemical Biology. He earned his M.B.A. from the MIT Sloan School of Management.

Carmichael is on the Board of Trustees of Duke University and the Berklee College of Music.